StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.21+0.28 (+2.01%)

Close on Nov 17, 2026Market cap $37.94MP/E –Yield –

Yarrow Bioscience r&d expenses

Research and development expenses are spending on new products and technology.

Yarrow Bioscience's R&D Expenses for the twelve months ending Jun 30, 2025 was $30.94M, up 78.3% year over year. For fiscal 2025 it was $19.24M, down 37.8% from the year before. Over ten years it grew 20.7% a year on average. The highest annual figure on record is $64.47M in fiscal 2018.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$19.24M-37.8%
FY2024Dec 31, 2024$30.95M+89.8%
FY2023Dec 31, 2023$16.31M-11.3%
FY2022Dec 31, 2022$18.39M-5.9%
FY2021Dec 31, 2021$19.54M-55.1%
FY2020Dec 31, 2020$43.53M-15.0%
FY2019Dec 31, 2019$51.20M-20.6%
FY2018Dec 31, 2018$64.47M+122.3%
FY2017Dec 31, 2017$29.01M+157.7%
FY2016Dec 31, 2016$11.26M+285.3%
FY2015Dec 31, 2015$2.92M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$788.00K-91.9%
Q1 FY2026Mar 31, 2026$817.00K-92.0%
Q2 FY2025Jun 30, 2025$4.88M-33.2%
Q1 FY2025Mar 31, 2025$6.12M+65.2%
Q4 FY2024Dec 31, 2024$9.68M+220.3%
Q3 FY2024Sep 30, 2024$10.25M+208.9%
Q2 FY2024Jun 30, 2024$7.31M+1.0%
Q1 FY2024Mar 31, 2024$3.71M+35.6%
Q4 FY2023Dec 31, 2023$3.02M-29.4%
Q3 FY2023Sep 30, 2023$3.32M-40.2%
Q2 FY2023Jun 30, 2023$7.23M+76.1%
Q1 FY2023Mar 31, 2023$2.73M-38.6%
Q4 FY2022Dec 31, 2022$4.28M-1.0%
Q3 FY2022Sep 30, 2022$5.55M-6.3%
Q2 FY2022Jun 30, 2022$4.11M-18.6%
Q1 FY2022Mar 31, 2022$4.45M+4.6%
Q4 FY2021Dec 31, 2021$4.32M-44.8%
Q3 FY2021Sep 30, 2021$5.92M-10.7%
Q2 FY2021Jun 30, 2021$5.05M-61.5%
Q1 FY2021Mar 31, 2021$4.26M-73.3%
Q4 FY2020Dec 31, 2020$7.84M-48.9%
Q3 FY2020Sep 30, 2020$6.62M-46.8%
Q2 FY2020Jun 30, 2020$13.12M+4.5%
Q1 FY2020Mar 31, 2020$15.95M+47.1%
Q4 FY2019Dec 31, 2019$15.35M-42.2%
Q3 FY2019Sep 30, 2019$12.45M+16.7%
Q2 FY2019Jun 30, 2019$12.56M-22.6%
Q1 FY2019Mar 31, 2019$10.85M-1.6%
Q4 FY2018Dec 31, 2018$26.56M+151.9%
Q3 FY2018Sep 30, 2018$10.67M+33.2%
Q2 FY2018Jun 30, 2018$16.23M+197.2%
Q1 FY2018Mar 31, 2018$11.02M+120.8%
Q4 FY2017Dec 31, 2017$10.55M–
Q3 FY2017Sep 30, 2017$8.01M–
Q2 FY2017Jun 30, 2017$5.46M–
Q1 FY2017Mar 31, 2017$4.99M–

More Yarrow Bioscience figures

See a number that looks wrong?